drugset / Trial / NCT00413049

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

NCT00413049

Phase 3 Completed 698 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of the fixed combination of valsartan/amlodipine in adult patients with mild to moderate hypertension

Timeline

Start
2007-01
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 5 mg Oral
Subject Valsartan Small molecule 80 mg Oral